MarketScreener Strategies Neurocrine Biosciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 02:30:00 13/12/2025 am IST			5-day change	1st Jan Change
152.80 ^USD	-1.26%		-1.74%	+11.94%

10/12	Neurocrine Biosciences Insider Sold Shares Worth $698,615, According to a Recent SEC Filing	MT
08/12	RBC Raises Price Target on Neurocrine Biosciences to $180 From $160, Keeps Outperform Rating	MT

November 25, 2025 at 05:49 pm IST

No results for this search

Neurocrine's collaboration for pipeline and market expansion

November 25, 2025 at 05:49 pm IST